The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ashe Andrew D. since 2013.
This trader's CIK number is 1573163.
At the time of last reporting, Ashe Andrew D. was the See Remarks of Verve Therapeutics, Inc.. (stock ticker symbol VERV).
Also see all insider trading activities at Verve Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | VERV | 0 | $0 | 2,681 | $11,126 | 9,000 | $0 |
2024 | VERV | 76,000 | $475,760 | 0 | $0 | 0 | $0 |
2021 | VERV | 4,000 | $128,419 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2016 | DYAX | 0 | $0 | 0 | $0 | 297,401 | $1,483,733 |
2015 | DYAX | 0 | $0 | 66,220 | $1,569,226 | 62,320 | $128,379 |
2014 | DYAX | 0 | $0 | 32,723 | $327,502 | 30,000 | $44,400 |
2013 | DYAX | 0 | $0 | 32,500 | $139,750 | 32,500 | $55,412 |
1. Verve Therapeutics, Inc. (VERV)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-04-01 | VERV | Option Ex | 9,000 | .00 | 0 |
2025-04-02 | VERV | Sale | 2,681 | 4.15 | 11,126 |
2024-05-14 | VERV | Buy | 76,000 | 6.26 | 475,760 |
2021-12-02 | VERV | Buy | 4,000 | 32.10 | 128,419 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-01-14 | DYAX | Option Ex | 297,401 | 4.99 | 1,483,733 |
2015-08-03 | DYAX | Option Ex | 62,320 | 2.06 | 128,379 |
2015-08-03 | DYAX | Sale | 62,320 | 24.21 | 1,509,016 |
2015-03-06 | DYAX | Sale | 2,400 | 15.50 | 37,200 |
2015-02-26 | DYAX | Sale | 1,500 | 15.34 | 23,010 |
2014-03-03 | DYAX | Option Ex | 30,000 | 1.48 | 44,400 |
2014-03-03 | DYAX | Sale | 30,000 | 10.00 | 300,000 |
2014-02-26 | DYAX | Sale | 2,723 | 10.10 | 27,502 |
2013-08-13 | DYAX | Option Ex | 32,500 | 1.71 | 55,412 |
2013-08-13 | DYAX | Sale | 32,500 | 4.30 | 139,750 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ashe Andrew D. (See Remarks of Verve Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.